Ionis Pharmaceuticals Overview
Ionis Pharmaceuticals Target Price
Where could IONS trade next? Consensus target price: $100.
Get informed when a big investor buys or sells
+ FollowShare Price
$56.53
Average Target Price
$100.71
78.1% upside
78.1% upside17 analysts in the last 4 months
High: $130 | Low: $69
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-30 | H.C. WainwrightMitchell Kapoor | $115 | 103.4% upside |  |
| 2026-07-29 | Goldman Sachs | $69 | 22.1% upside | |
| 2026-07-21 | GuggenheimDebjit Chattopadhyay | $89 | 57.4% upside | |
| 2026-07-13 | RBC CapitalLuca Issi | $85 | 50.4% upside | |
| 2026-07-10 | Morgan Stanley | $110 | 94.6% upside | |
| 2026-07-10 | Canaccord GenuityGary Nachman | $95 | 68.1% upside | |
| 2026-07-10 | BarclaysEliana Merle | $90 | 59.2% upside | |
| 2026-07-09 | Jefferies | $90 | 59.2% upside | |
| 2026-07-09 | NeedhamJoseph Stringer | $86 | 52.1% upside | |
| 2026-07-09 | Raymond James | $87 | 53.9% upside | |
| 2026-06-25 | H.C. Wainwright | $130 | 130% upside | |
| 2026-06-24 | Goldman Sachs | $75 | 32.7% upside | |
| 2026-04-30 | Oppenheimer | $111 | 96.4% upside | |
| 2026-04-30 | H.C. Wainwright | $125 | 121.1% upside | |
| 2026-04-30 | BarclaysEliana Merle | $115 | 103.4% upside | |
| 2026-04-21 | Morgan Stanley | $130 | 130% upside | |
| 2026-04-20 | Canaccord Genuity | $110 | 94.6% upside | |
| 2026-04-10 | Raymond JamesTiago Fauth | $104 | 84% upside | |
| 2026-02-25 | Morgan StanleyMichael Ulz | $95 | 68.1% upside | |
| 2026-02-25 | Needham | $103 | 82.2% upside | |
| 2026-02-06 | Piper Sandler | $87 | 53.9% upside | |
| 2026-01-05 | Wells Fargo | $100 | 76.9% upside | |
| 2025-12-17 | RBC CapitalLuca Issi | $95 | 68.1% upside | |
| 2025-12-15 | Leerink Partners | $100 | 76.9% upside | |
| 2025-11-04 | Piper Sandler | $77 | 36.2% upside | |
| 2025-10-30 | H.C. Wainwright | $100 | 76.9% upside | |
| 2025-10-30 | Morgan Stanley | $94 | 66.3% upside | |
| 2025-10-30 | Cowen & Co. | $99 | 75.1% upside | |
| 2025-10-30 | Barclays | $95 | 68.1% upside | |
| 2025-10-16 | Morgan Stanley | $90 | 59.2% upside | |
| 2025-10-08 | OppenheimerJustin Kim | $90 | 59.2% upside | |
| 2025-10-06 | Stifel Nicolaus | $67 | 18.5% upside | |
| 2025-09-26 | Goldman Sachs | $65 | 15% upside | |
| 2025-09-23 | BarclaysGena Wang | $82 | 45.1% upside | |
| 2025-09-22 | Raymond JamesGary Nachman | $75 | 32.7% upside | |
| 2025-09-04 | RBC Capital | $80 | 41.5% upside | |
| 2025-09-03 | BMO CapitalKostas Biliouris | $70 | 23.8% upside | |
| 2025-09-02 | BarclaysGena Wang | $78 | 38% upside | |
| 2025-09-02 | Morgan StanleyMichael Ulz | $71 | 25.6% upside | |
| 2025-09-02 | Jefferies | $96 | 69.8% upside | |
| 2025-09-02 | H.C. WainwrightMitchell Kapoor | $95 | 68.1% upside | |
| 2025-08-22 | H.C. Wainwright | $70 | 23.8% upside | |
| 2025-08-22 | Wells FargoYanan Zhu | $82 | 45.1% upside | |
| 2025-08-22 | Barclays | $58 | 2.6% upside | |
| 2025-08-21 | Stifel Nicolaus | $43 |  23.9% downside | |
| 2025-07-31 | H.C. Wainwright | $65 | 15% upside | |
| 2025-07-30 | Morgan Stanley | $62 | 9.7% upside | |
| 2024-10-09 | GuggenheimDebjit Chattopadhyay | $65 | 15% upside | |
| 2024-08-02 | BMO CapitalKostas Biliouris | $60 | 6.1% upside | |
| 2024-07-24 | Leerink PartnersMani Foroohar | $62 | 9.7% upside | |